Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Evaxion Biotech Q2 EPS $(0.36) Down From $(0.24) YoY

Evaxion Biotech (NASDAQ:EVAX) reported quarterly losses of $(0.36) per share. This is a 50 percent decrease over losses of $(0.24) per share from the same period last year.

byBenzinga Newsdesk

August 12, 2021

1 minute read

Evaxion Biotech (NASDAQ:EVAX) reported quarterly losses of $(0.36) per share. This is a 50 percent decrease over losses of $(0.24) per share from the same period last year.

Bankruptcy Judge Orders Silvergate Bank To Release $9.9M To Crypto Lender BlockFi

By Murtuza Merchant

Today, 8:59 AM

After filing for bankruptcy protection in November 2022, BlockFi has been granted the release of almost $9.9 million from Silvergate Capital Corp (NYSE: SI) by a U.S. bankruptcy judge.

BRPHF

Earnings

Looking Into Clear Channel Outdoor’s Return On Capital Employed

By Benzinga Insights

Today, 8:59 AM

According to Benzinga Pro, during Q4, Clear Channel Outdoor (NYSE:CCO) earned $65.53 million, a 260.65% increase from the preceding quarter. Clear Channel Outdoor also posted a total of $742.71 million in sales, a 24.53% increase since Q3.

CCO